Cordis’ Radianz Radial Peripheral System Used in First-in-Human Procedure for Vascular Disease
Shots:
- The system was used at ACV in Grand Rapids, Michigan as a comprehensive treatment solution for vascular disease & to improve patients' QoL. The system portfolio is expected to launch in 2022 in the US & soon in Japan
- The system includes the Brite Tip Radianz guiding sheath to optimize lower extremity lesion access, Saberx Radianz Pta Catheter to facilitate treatment & the S.M.A.R.T. Radianz Vascular Stent System to maintain patency for favorable outcomes
- The system is intended for radial access & showed fewer vascular complications (≤1% vs 2% to 4%), 80% patient satisfaction than femoral access, 85% reduction in access site complications, 73% in major bleeding & time can be reduced from hrs. to min. with improved mobility & comfort
Ref: PRNewswire | Image: Cordis
Click here to read the full press release
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.
